Value-based health care for inflammatory bowel diseases
Welmoed K van Deen1, Eric Esrailian1, Daniel W Hommes2
1Center for Inflammatory Bowel Diseases, Melvin and Bren Simon Digestive Diseases Center, David Geffen School of Medicine, University of California Los Angeles, USA.
Value-based healthcare (VBHC) offers a solution to rising medical costs by focusing on outcomes achieved per cost incurred. Implementing VBHC requires accurate measurement, reporting, improvement identification, and performance rewards.
Area of Science:
- Health Economics
- Healthcare Management
Background:
- Global healthcare systems face immense pressure from escalating costs.
- Inflammatory bowel diseases (IBD) represent a significant financial burden among chronic conditions.
- Physicians are increasingly involved in health economics and cost-containment strategies.
Purpose of the Study:
- To explore the foundational components of value-based healthcare (VBHC).
- To review existing evidence on VBHC applications in inflammatory bowel diseases (IBD).
- To share practical experiences to guide other healthcare providers in implementing VBHC.
Main Methods:
- Conceptual exploration of VBHC principles.
- Systematic review of literature on VBHC in IBD.
- Case study presentation of institutional experience.
Main Results:
- VBHC centers on maximizing health outcomes relative to costs.
- Four key components are essential for effective VBHC implementation: measurement, reporting, improvement, and rewards.
- Evidence for VBHC in IBD is emerging, highlighting its potential for cost containment and quality improvement.
Conclusions:
- VBHC presents a promising framework for addressing healthcare cost challenges.
- Successful VBHC implementation necessitates robust data infrastructure and a commitment to continuous improvement.
- The principles and experiences discussed offer a roadmap for adopting VBHC in IBD care and beyond.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids